{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T16:23:38Z","timestamp":1795191818999,"version":"4.10.3"},"reference-count":507,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is now a large body of evidence suggesting that the decline in ovarian function with menopause is associated with spontaneous increases in proinflammatory cytokines. The cytokines that have obtained the most attention are IL-1, IL-6, and TNF-\u03b1. The exact mechanisms by which estrogen interferes with cytokine activity are still incompletely known but may potentially include interactions of the ER with other transcription factors, modulation of nitric oxide activity, antioxidative effects, plasma membrane actions, and changes in immune cell function. Experimental and clinical studies strongly support a link between the increased state of proinflammatory cytokine activity and postmenopausal bone loss. Preliminary evidence suggests that these changes also might be relevant to vascular homeostasis and the development of atherosclerosis. Better knowledge of the mechanisms and the time course of these interactions may open new avenues for the prevention and treatment of some of the most prevalent and important disorders in postmenopausal women.<\/jats:p>","DOI":"10.1210\/edrv.23.1.0456","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T18:26:14Z","timestamp":1389205574000},"page":"90-119","source":"Crossref","is-referenced-by-count":788,"title":["Changes in Proinflammatory Cytokine Activity after Menopause"],"prefix":"10.1210","volume":"23","author":[{"given":"Johannes","family":"Pfeilschifter","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Berufsgenossenschaftliche Kliniken Bergmannsheil, University of Bochum, D-44789 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Ko\u0308ditz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Berufsgenossenschaftliche Kliniken Bergmannsheil, University of Bochum, D-44789 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pfohl","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Berufsgenossenschaftliche Kliniken Bergmannsheil, University of Bochum, D-44789 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Schatz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Berufsgenossenschaftliche Kliniken Bergmannsheil, University of Bochum, D-44789 Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2020071612145003100_R1","first-page":"4025","article-title":"Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.","volume":"84","author":"Burger","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9343(97)90022-X","article-title":"The crippling consequences of fractures and their impact on quality of life.","volume":"103","author":"Cooper","year":"1997","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"2020071612145003100_R3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s003950050225","article-title":"Women and heart disease","volume":"93","author":"Maxwell","year":"1998","journal-title":"Basic Res Cardiol"},{"key":"2020071612145003100_R4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1096\/fasebj.10.5.8621060","article-title":"The vascular protective effects of estrogen.","volume":"10","author":"Farhat","year":"1996","journal-title":"FASEB J"},{"key":"2020071612145003100_R5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system.","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/edrv-15-3-301","article-title":"Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis.","volume":"15","author":"Prince","year":"1994","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.86.7.2398","article-title":"Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.","volume":"86","author":"Pacifici","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R8","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.","volume":"88","author":"Pacifici","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6.","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"2020071612145003100_R10","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1172\/JCI117187","article-title":"Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.","volume":"93","author":"Kimble","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R11","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","article-title":"Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.","volume":"94","author":"Kitazawa","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R12","first-page":"3351","article-title":"Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement.","volume":"80","author":"Bismar","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R13","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1210\/endo.133.2.8393776","article-title":"Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.","volume":"133","author":"Passeri","year":"1993","journal-title":"Endocrinology"},{"key":"2020071612145003100_R14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ajcp\/105.5.589","article-title":"Cytokine function: a study in biologic diversity.","volume":"105","author":"Cohen","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"2020071612145003100_R15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jbmr.5650111214","article-title":"Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.","volume":"11","author":"Vargas","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1359\/jbmr.1998.13.2.185","article-title":"IL-1\u03b1, IL-1\u03b2, IL-6, and TNF-\u03b1 steady state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice.","volume":"13","author":"Van Bezooijen","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jbmr.5650090821","article-title":"Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women.","volume":"9","author":"McKane","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R18","first-page":"A86","article-title":"Increased serum-soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration","volume":"10","author":"Girasole","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/joe.0.1640129","article-title":"Estrogen mediates the sex difference in post-burn immunosuppression.","volume":"164","author":"Gregory","year":"2000","journal-title":"J Endocrinol"},{"key":"2020071612145003100_R20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0960-0760(00)00138-2","article-title":"The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers.","volume":"75","author":"Martinetti","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"2020071612145003100_R21","first-page":"S179","article-title":"In vivo demonstration of the negative transcriptional control of the IL-6 gene by estrogen using IL-6 promoter-luciferase transgenic mice","volume":"14","author":"O\u2019Brien","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02214935","article-title":"Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause.","volume":"14","author":"Cantatore","year":"1995","journal-title":"Clin Rheumatol"},{"key":"2020071612145003100_R23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2265.1999.00896.x","article-title":"Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro.","volume":"51","author":"Girasole","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612145003100_R24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2141.1999.01158.x","article-title":"Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease.","volume":"104","author":"Woodward","year":"1999","journal-title":"Brit J Haematol"},{"key":"2020071612145003100_R25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"2020071612145003100_R26","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1172\/JCI119729","article-title":"Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.","volume":"100","author":"Lin","year":"1997","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-0378(00)00087-5","article-title":"The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopause.","volume":"50","author":"Keller","year":"2001","journal-title":"J Reprod Immunol"},{"key":"2020071612145003100_R28","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1074\/jbc.272.23.15003","article-title":"Isolation and characterization of the human gp130 promoter-regulation by STATS.","volume":"272","author":"O\u2019Brien","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-5793(00)02296-1","article-title":"Cross-talk between signal transducer and activator of transcription 3 and ER signaling.","volume":"486","author":"Yamamoto","year":"2000","journal-title":"FEBS Lett"},{"key":"2020071612145003100_R30","doi-asserted-by":"crossref","first-page":"31839","DOI":"10.1074\/jbc.M105185200","article-title":"Activation of estrogen receptor blocks IL-6 inducible cell growth of human multiple myeloma involving molecular cross-talk between ER and STAT3 mediated by a co-regulator PIAS3.","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF01623843","article-title":"Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro.","volume":"2","author":"Rickard","year":"1992","journal-title":"Osteoporos Int"},{"key":"2020071612145003100_R32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:11:1:13","article-title":"The expression of transforming growth factor-\u03b2 and interleukin-1\u03b2 mRNA and the response to 1,25(OH)2D3\u2032 17\u03b2-estradiol, and testosterone is age-dependent in primary cultures of mouse-derived osteoblasts in vitro.","volume":"11","author":"Wang","year":"1999","journal-title":"Endocrine"},{"key":"2020071612145003100_R33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jbmr.5650050912","article-title":"Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women.","volume":"5","author":"Ralston","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R34","first-page":"377","article-title":"Estrogen modulates the expression of tumor necrosis factor \u03b1 mRNA in phorbol ester-stimulated human monocytic THP-1 cells.","volume":"13","author":"Shanker","year":"1994","journal-title":"Lymphokine Cytokine Res"},{"key":"2020071612145003100_R35","doi-asserted-by":"crossref","first-page":"28890","DOI":"10.1074\/jbc.271.46.28890","article-title":"Estrogen deficiency increases the ability of stromal cells to support osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production.","volume":"271","author":"Kimble","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1902\/jop.1999.70.7.757","article-title":"Effects of sex hormones on production of interleukin-1 by human peripheral monocytes.","volume":"70","author":"Morishita","year":"1999","journal-title":"J Periodontol"},{"key":"2020071612145003100_R37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s001980170054","article-title":"Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study.","volume":"12","author":"Bernard-Poenaru","year":"2001","journal-title":"Osteoporos Int"},{"key":"2020071612145003100_R38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S8756-3282(01)00468-9","article-title":"The effect of 17\u03b2-estradiol on production of cytokines in cultures of peripheral blood.","volume":"29","author":"Rogers","year":"2001","journal-title":"Bone"},{"key":"2020071612145003100_R39","first-page":"18","article-title":"In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.","volume":"86","author":"Zuckerman","year":"1995","journal-title":"Immunology"},{"key":"2020071612145003100_R40","first-page":"2043","article-title":"In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status.","volume":"83","author":"Cheleuitte","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0039-128X(01)00104-0","article-title":"Aromatase in synovial cells from postmenopausal women.","volume":"66","author":"Le Bail","year":"2001","journal-title":"Steroids"},{"key":"2020071612145003100_R42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","article-title":"17\u03b2-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.","volume":"89","author":"Girasole","year":"1992","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI117100","article-title":"17\u03b2-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.","volume":"93","author":"Pottratz","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R44","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/MCB.15.9.4971","article-title":"Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-\u03ba-B and C\/EBP-\u03b2.","volume":"15","author":"Stein","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2020071612145003100_R45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jbmr.5650110208","article-title":"Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors.","volume":"11","author":"Kassem","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/01.ATV.18.9.1498","article-title":"Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17\u03b2-estradiol.","volume":"18","author":"Sukovich","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071612145003100_R47","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0029-1211994","article-title":"Effects of 17\u03b2-estradiol and progesterone on interleukin-6 production and proliferation of human umbilical vein endothelial cells.","volume":"106","author":"Keck","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071612145003100_R48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4049\/jimmunol.163.1.374","article-title":"Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis.","volume":"163","author":"Miyamoto","year":"1999","journal-title":"J Immunol"},{"key":"2020071612145003100_R49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archsurg.135.4.425","article-title":"Do female sex steroids adversely or beneficially affect the depressed immune responses in males after trauma-hemorrhage?","volume":"135","author":"Knoferl","year":"2000","journal-title":"Arch Surg"},{"key":"2020071612145003100_R50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00000658-200011000-00009","article-title":"Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals.","volume":"232","author":"Mizushima","year":"2000","journal-title":"Ann Surg"},{"key":"2020071612145003100_R51","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/endo.142.7.8243","article-title":"Differential effects of estradiol on the adrenocorticotropin responses to interleukin-6 and interleukin-1 in the monkey.","volume":"142","author":"Xiao","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612145003100_R52","first-page":"2403","article-title":"Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women.","volume":"86","author":"Puder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2020071612145003100_R53","first-page":"S147","article-title":"Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause","volume":"14","author":"Scheidt-Nave","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R54","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jcem.85.3.6355","article-title":"Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study.","volume":"85","author":"Straub","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1507\/endocrj.47.205","article-title":"Effect of estrogen and progesterone on gene expression of growth regulatory molecules and proto-oncogene in vascular smooth muscle cells.","volume":"47","author":"Okubo","year":"2000","journal-title":"Endocr J"},{"key":"2020071612145003100_R56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0165-5728(00)00374-X","article-title":"Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia\/hypoglycemia followed by reoxygenation.","volume":"112","author":"Wang","year":"2001","journal-title":"J Neuroimmunol"},{"key":"2020071612145003100_R57","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200009073431011","article-title":"The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.","volume":"343","author":"Dinarello","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2020071612145003100_R58","first-page":"131","article-title":"Estrogen decreases the steady state levels of the IL-1 signaling receptor (type I) while increasing those of the IL-1 decoy receptor (type II) in human osteoclast-like cells","volume":"12","author":"Sunyer","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R59","first-page":"513","article-title":"Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women.","volume":"81","author":"Kassem","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R60","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.4049\/jimmunol.160.10.5098","article-title":"Regulation of TNF-\u03b1 production in activated mouse macrophages by progesterone.","volume":"160","author":"Miller","year":"1998","journal-title":"J Immunol"},{"key":"2020071612145003100_R61","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0024-3205(01)01304-2","article-title":"Cytokine and nitric oxide release by J774A.1 macrophages is not regulated by estradiol.","volume":"69","author":"Woodfork","year":"2001","journal-title":"Life Sci"},{"key":"2020071612145003100_R62","author":"Gordon","year":"1999"},{"key":"2020071612145003100_R63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S8756-3282(99)00240-9","article-title":"Ovariectomy does not induce osteopenia through inteleukin-6 in rhesus monkeys (Macaca mulatta).","volume":"26","author":"Keller","year":"2000","journal-title":"Bone"},{"key":"2020071612145003100_R64","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1210\/endo.136.9.7649114","article-title":"Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-\u03b1 is not regulated by ovarian steroids.","volume":"136","author":"Rifas","year":"1995","journal-title":"Endocrinology"},{"key":"2020071612145003100_R65","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1210\/endo.130.5.1572280","article-title":"Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1\u03b2 and tumor necrosis factor-\u03b1: lack of regulation by 17\u03b2-estradiol.","volume":"130","author":"Chaudhary","year":"1992","journal-title":"Endocrinology"},{"key":"2020071612145003100_R66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/cyto.2001.0892","article-title":"Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression.","volume":"15","author":"Dovio","year":"2001","journal-title":"Cytokine"},{"key":"2020071612145003100_R67","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1210\/endo.140.6.6763","article-title":"Expression of the interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture.","volume":"140","author":"Maret","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R68","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1359\/jbmr.1998.13.10.1577","article-title":"Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.","volume":"13","author":"Rogers","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R69","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(00)00952-9","article-title":"Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.","volume":"36","author":"Zanger","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2020071612145003100_R70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0008-8749(95)80007-6","article-title":"Steroid sex hormones regulate the release of tumor necrosis factor by macrophages.","volume":"160","author":"Chao","year":"1995","journal-title":"Cell Immunol"},{"key":"2020071612145003100_R71","first-page":"247","article-title":"Effect of oestradiol on interleukin 1 synthesis by macrophages.","volume":"10","author":"Hu","year":"1998","journal-title":"Int J Immunopharmacol"},{"key":"2020071612145003100_R72","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jcem-68-2-364","article-title":"Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women.","volume":"68","author":"Stock","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R73","first-page":"2480","article-title":"There is no difference in spontaneous and 17\u03b2-estradiol-induced interleukin-1\u03b2 release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss.","volume":"80","author":"Hogasen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0960-0760(98)00042-9","article-title":"Effect of estrogens on IL-1\u03b2 promoter activity.","volume":"66","author":"Ruh","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612145003100_R75","first-page":"157","article-title":"Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro.","volume":"11","author":"Li","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"2020071612145003100_R76","first-page":"743","article-title":"Effects of estrogens on interleukin-6 production in rheumatoid fibroblast-like synoviocytes.","volume":"18","author":"Kawasaki","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"2020071612145003100_R77","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1359\/jbmr.2000.15.8.1545","article-title":"Cytokines and bone loss in a 5-year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.","volume":"15","author":"Abrahamsen","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2796.1999.00545.x","article-title":"Oestrogen receptors-an overview.","volume":"246","author":"Enmark","year":"1999","journal-title":"J Intern Med"},{"key":"2020071612145003100_R79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(89)90237-7","article-title":"Gene regulation by steroid hormones.","volume":"56","author":"Beato","year":"1989","journal-title":"Cell"},{"key":"2020071612145003100_R80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1043-2760(99)00177-0","article-title":"The molecular pharmacology of SERMS.","volume":"10","author":"McDonnell","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612145003100_R81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0960-0760(98)00147-2","article-title":"An estrogen receptor basis for raloxifene action in bone.","volume":"69","author":"Bryant","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"Suppl 1","key":"2020071612145003100_R82","first-page":"I7","article-title":"Effects of raloxifene and hormone replacement therapy on homocysteine and c-reactive protein levels in postmenopausal women","volume":"17","author":"Paul","year":"1998","journal-title":"Circulation"},{"key":"2020071612145003100_R83","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.16.1.225","article-title":"NF-\u03baB and REL proteins: evolutionary conserved mediators of immune responses.","volume":"16","author":"Ghosh","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"2020071612145003100_R84","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1073\/pnas.96.10.5668","article-title":"Defining therapeutic targets by using adenovirus: blocking NF-\u03baB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.","volume":"96","author":"Bondeson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R85","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1073\/pnas.91.2.752","article-title":"Physical association and functional antagonism between the p65 subunit of transcription factor NF-\u03baB and the glucocorticoid receptor.","volume":"91","author":"Ray","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R86","first-page":"435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-\u03baB and steroid receptor-signaling pathways.","volume":"20","author":"McKay","year":"1999","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R87","doi-asserted-by":"crossref","first-page":"24151","DOI":"10.1074\/jbc.271.39.24151","article-title":"Mutual transcriptional interference between RelA and androgen receptor.","volume":"271","author":"Palvimo","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R88","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1074\/jbc.271.11.6217","article-title":"Negative interaction between the RelA(p65) subunit of NF-\u03baB and the progesterone receptor.","volume":"271","author":"Kalkhoven","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R89","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1074\/jbc.274.12.7674","article-title":"Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NF\u03baB.","volume":"274","author":"Na","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R90","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPAR\u03b1 but not by PPAR\u03b3 activators.","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"2020071612145003100_R91","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1046\/j.1471-4159.1999.0731453.x","article-title":"Sodium salicylate and 17\u03b2-estradiol attenuate nuclear transcription factor NF-\u03baB translocation in cultured rat astroglial cultures following exposure to amyloid A \u03b2 (1\u201340) and lipopolysaccharides.","volume":"73","author":"Dodel","year":"1999","journal-title":"J Neurochem"},{"key":"2020071612145003100_R92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0960-0760(98)00078-8","article-title":"The oestrogen receptor regulates NF\u03baB and AP-1 activity in a cell-specific manner.","volume":"67","author":"Cerillo","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612145003100_R93","first-page":"713","article-title":"Involvement of CCAAT\/enhancer-binding protein and nuclear factor-\u03baB binding sites in interleukin-6 promoter inhibition by estrogens.","volume":"10","author":"Galien","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071612145003100_R94","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0897.1997.tb00275.x","article-title":"Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages.","volume":"38","author":"Deshpande","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"2020071612145003100_R95","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/endo.141.9.7646","article-title":"The role of CBP in estrogen receptor cross-talk with nuclear factor-\u03baB in HepG2 cells.","volume":"141","author":"Harnish","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R96","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1006\/bbrc.2001.5519","article-title":"Estrogen effects in the myocardium: inhibition of NF-\u03baB DNA binding by estrogen receptor-\u03b1 and -\u03b2.","volume":"286","author":"Pelzer","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R97","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/endo.142.3.8003","article-title":"4-hydroxytamoxifen trans-represses nuclear factor-\u03baB activity in human osteoblastic U2-OS cells through estrogen receptor (ER) \u03b1, and not through ER\u03b2.","volume":"142","author":"Quaedackers","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612145003100_R98","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/nar\/25.12.2424","article-title":"Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-\u03baB site.","volume":"25","author":"Galien","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"2020071612145003100_R99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0960-0760(96)00175-6","article-title":"Characterization of mechanisms of interleukin-6 gene expression by estrogen receptor.","volume":"60","author":"Kurebayashi","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612145003100_R100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0968-0004(00)01617-0","article-title":"The Rel\/NF-\u03baB family: friend and foe.","volume":"25","author":"Perkins","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"2020071612145003100_R101","doi-asserted-by":"crossref","first-page":"29291","DOI":"10.1074\/jbc.273.45.29291","article-title":"Nuclear integration of glucocorticoid receptor and NF-\u03baB signaling by CREB-binding protein and steroid receptor coactivator-1.","volume":"273","author":"Sheppard","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R102","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.87.11.1006","article-title":"Competition for p300 regulates transcription by estrogen receptors and nuclear factor-\u03baB in human coronary smooth muscle cells.","volume":"87","author":"Speir","year":"2000","journal-title":"Circ Res"},{"key":"2020071612145003100_R103","doi-asserted-by":"crossref","first-page":"18375","DOI":"10.1074\/jbc.M100800200","article-title":"Direct acetylation of the estrogen receptor \u03b1 hinge region by p300 regulates transactivation and hormone sensitivity.","volume":"276","author":"Wang","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1006\/bbrc.1998.8324","article-title":"Estrogen inhibits phorbol ester-induced I \u03ba B \u03b1 transcription and protein degradation.","volume":"244","author":"Sun","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R105","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.90.21.10193","article-title":"Transcription factors NF-IL6 and NF-\u03baB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.","volume":"90","author":"Matsusaka","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R106","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1210\/endo.140.10.7063","article-title":"The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17\u03b2-estradiol and prolactin.","volume":"140","author":"Deb","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0960-0760(98)00115-0","article-title":"A novel human estrogen receptor \u03b2: identification and functional analysis of additional N-terminal amino acids.","volume":"67","author":"Bhat","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612145003100_R108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1210\/endo.141.1.7233","article-title":"Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells.","volume":"141","author":"Inadera","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R109","first-page":"543","article-title":"Synergistic activation of the serontonin-1a receptor by nuclear factor-\u03baB and estrogen.","volume":"15","author":"Wissink","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071612145003100_R110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(88)90076-1","article-title":"The c-Fos protein interacts with c-Jun\/AP-1 to stimulate transcription of AP-1 responsive genes.","volume":"54","author":"Chiu","year":"1988","journal-title":"Cell"},{"key":"2020071612145003100_R111","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1210\/endo.141.8.7610","article-title":"Estradiol stimulation of c-fos and c-jun expressions and activator protein-1 deoxyribonucleic acid binding activity in rat white adipocyte.","volume":"141","author":"Garcia","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R112","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0092-8674(90)90422-B","article-title":"Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex.","volume":"63","author":"Gaub","year":"1990","journal-title":"Cell"},{"key":"2020071612145003100_R113","doi-asserted-by":"crossref","first-page":"14103","DOI":"10.1016\/S0021-9258(19)85214-6","article-title":"Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis.","volume":"268","author":"Philips","year":"1993","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R114","doi-asserted-by":"crossref","first-page":"16433","DOI":"10.1016\/S0021-9258(17)34025-5","article-title":"Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.","volume":"269","author":"Umayahara","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R115","first-page":"443","article-title":"Tamoxifen activation of the estrogen receptor\/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.","volume":"9","author":"Webb","year":"1995","journal-title":"Mol Endocrinol"},{"key":"2020071612145003100_R116","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.277.5331.1508","article-title":"Differential ligand activation of estrogen receptors ER \u03b1 and ER \u03b2 at AP1 sites.","volume":"277","author":"Paech","year":"1997","journal-title":"Science"},{"key":"2020071612145003100_R117","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/mend.12.7.0133","article-title":"FRA-1 expression level modulates regulation of activator-protein-1 activity by estradiol in breast cancer cells.","volume":"12","author":"Philips","year":"1998","journal-title":"Mol Endocrinol"},{"key":"2020071612145003100_R118","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1210\/endo.137.8.8754772","article-title":"Transcriptional repression of the ovine follicle-stimulating hormone-\u03b2 gene by 17\u03b2-estradiol.","volume":"137","author":"Miller","year":"1996","journal-title":"Endocrinology"},{"key":"2020071612145003100_R119","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jnr.490400203","article-title":"Positive and negative effects of nuclear receptors on transcription activation by AP-1 of the human choline acetyltransferase proximal promoter.","volume":"40","author":"Schmitt","year":"1995","journal-title":"J Neurosci Res"},{"key":"2020071612145003100_R120","doi-asserted-by":"crossref","first-page":"15161","DOI":"10.1073\/pnas.96.26.15161","article-title":"Estradiol repression of tumor necrosis factor-\u03b1 transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.","volume":"96","author":"An","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R121","doi-asserted-by":"crossref","first-page":"17808","DOI":"10.1074\/jbc.M100953200","article-title":"Estrogen receptor \u03b2-selective transcriptional activity and recruitment of coregulators by phytoestrogens.","volume":"276","author":"An","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R122","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1074\/jbc.M008384200","article-title":"Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway.","volume":"276","author":"Jakacka","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R123","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI7094","article-title":"Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.","volume":"104","author":"Srivastava","year":"1999","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R124","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R125","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1021\/bi010379h","article-title":"Structure-function evaluation of ER \u03b1 and \u03b2 interplay with SRC family coactivators. ER selective ligands.","volume":"40","author":"Wong","year":"2001","journal-title":"Biochemistry"},{"key":"2020071612145003100_R126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: a key role in inflammatory diseases.","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R127","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3181\/00379727-206-43736","article-title":"The network of hematopoietic cytokines.","volume":"206","author":"Sachs","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071612145003100_R128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/323086a0","article-title":"Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, \u03b3-interferon and interleukin-1.","volume":"323","author":"Philip","year":"1986","journal-title":"Nature"},{"key":"2020071612145003100_R129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis.","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"2020071612145003100_R130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1242\/jeb.202.6.645","article-title":"Inducible NO synthase: role in cellular signaling.","volume":"202","author":"Beck","year":"1999","journal-title":"J Exp Biol"},{"key":"2020071612145003100_R131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF03401781","article-title":"Inducible nitric oxide synthase and inflammatory diseases.","volume":"6","author":"Zamora","year":"2000","journal-title":"Mol Med"},{"key":"2020071612145003100_R132","first-page":"H2311","article-title":"Gender differences in bioassayable endothelium-derived nitric oxide release from isolated rat aortae","volume":"267","author":"Kauser","year":"1994","journal-title":"Am J Physiol"},{"key":"2020071612145003100_R133","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00005344-199511000-00017","article-title":"Gender differences in atherosclerosis: possible role of nitric oxide.","volume":"26","author":"Hayashi","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"2020071612145003100_R134","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/endo.139.2.5910","article-title":"Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells.","volume":"139","author":"Armour","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612145003100_R135","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.4049\/jimmunol.163.7.3758","article-title":"Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: evidence for an estrogen surface receptor.","volume":"163","author":"Stefano","year":"1999","journal-title":"J Immunol"},{"key":"2020071612145003100_R136","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1210\/jcem.85.8.6853","article-title":"Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase.","volume":"85","author":"Simoncini","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R137","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1172\/JCI119426","article-title":"Vascular estrogen receptors and endothelial-derived nitric oxide production in the mouse aorta: gender difference and effect of estrogen receptor gene disruption.","volume":"99","author":"Rubanyi","year":"1997","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R138","first-page":"3056","article-title":"Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia.","volume":"83","author":"Stacey","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R139","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.HYP.25.4.848","article-title":"Circulating nitric oxide (nitrite\/nitrate) levels in postmenopausal women substituted with 17\u03b2-estradiol and norethisterone acetate.","volume":"25","author":"Rosselli","year":"1995","journal-title":"Hypertension"},{"key":"2020071612145003100_R140","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1359\/jbmr.1998.13.11.1755","article-title":"Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures.","volume":"13","author":"Jamal","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R141","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/009841000156501","article-title":"Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women.","volume":"60","author":"Konukoglu","year":"2000","journal-title":"J Toxicol Environ Health"},{"key":"2020071612145003100_R142","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI5347","article-title":"Estrogen receptor \u03b1 mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.","volume":"103","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R143","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.101.13.1594","article-title":"Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia.","volume":"101","author":"Stefano","year":"2000","journal-title":"Circulation"},{"key":"2020071612145003100_R144","doi-asserted-by":"crossref","first-page":"27071","DOI":"10.1074\/jbc.M100312200","article-title":"Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through G\u03b1i.","volume":"276","author":"Wyckoff","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.87.8.677","article-title":"Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-akt pathway in human endothelial cells.","volume":"87","author":"Haynes","year":"2000","journal-title":"Circ Res"},{"key":"2020071612145003100_R146","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/35035131","article-title":"Interaction of oestrogen receptor with the regulatory subunit of phosphatidiylinositol-3-OH kinase.","volume":"407","author":"Simoncini","year":"2000","journal-title":"Nature"},{"key":"2020071612145003100_R147","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00005344-199802000-00016","article-title":"Physiological concentrations of 17\u03b2-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system.","volume":"31","author":"Hayashi","year":"1998","journal-title":"J Cardiovasc Pharamacol"},{"key":"2020071612145003100_R148","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1210\/endo.140.5.6694","article-title":"17\u03b2-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells.","volume":"140","author":"Zancan","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R149","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/endo.141.4.7404","article-title":"17\u03b2-Estradiol antiinflammatory activity in carrageenan-induced pleurisy.","volume":"141","author":"Cuzzocrea","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-5728(00)00386-6","article-title":"Female sex steroids: effects upon microglial cell activation.","volume":"111","author":"Drew","year":"2000","journal-title":"J Neuroimmunol"},{"key":"2020071612145003100_R151","first-page":"H1317","article-title":"NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-\u03b1","volume":"277","author":"De Frutos","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071612145003100_R152","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00003246-199905000-00024","article-title":"Effect of the nitric oxide inhibitor, L-N(G)-monomethylarginine, on accumulation of interleukin-6 and interleukin-8, and nuclear factor-\u03baB activity in a human endothelial cell line.","volume":"27","author":"Galley","year":"1999","journal-title":"Crit Care Med"},{"key":"2020071612145003100_R153","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/joca.1998.0218","article-title":"Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats.","volume":"7","author":"Jouzeau","year":"1999","journal-title":"Osteoarthritis Cartilage"},{"key":"2020071612145003100_R154","doi-asserted-by":"crossref","first-page":"33190","DOI":"10.1074\/jbc.274.47.33190","article-title":"A Sp1 binding site of the tumor necrosis factor \u03b1 promoter functions as a nitric oxide response element.","volume":"274","author":"Wang","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2567.1999.00685.x","article-title":"Role of nitric oxide and prostaglandins in the potentiating effects of calcitonin gene-related peptide on lipopolysaccharide-induced interleukin-6 release from mouse peritoneal macrophages.","volume":"96","author":"Tang","year":"1999","journal-title":"Immunology"},{"key":"2020071612145003100_R156","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1164\/ajrccm.161.1.9902113","article-title":"Nitric oxide modulates interleukin-1\u03b2 and tumor necrosis factor-\u03b1 synthesis by alveolar macrophages in pulmonary tuberculosis.","volume":"161","author":"Kuo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2020071612145003100_R157","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.CIR.101.8.931","article-title":"Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase.","volume":"101","author":"Yamashita","year":"2000","journal-title":"Circulation"},{"key":"2020071612145003100_R158","doi-asserted-by":"crossref","first-page":"14214","DOI":"10.1074\/jbc.270.23.14214","article-title":"Induction and stabilization of I\u03baB\u03b1 by nitric oxide mediates inhibition of NF-\u03baB.","volume":"270","author":"Peng","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R159","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.RES.76.6.980","article-title":"Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells.","volume":"76","author":"Zeiher","year":"1995","journal-title":"Circ Res"},{"key":"2020071612145003100_R160","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.4049\/jimmunol.161.8.4122","article-title":"Nitric oxide prevents IL-1\u03b2 and INF-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1\u03b2-converting enzyme).","volume":"161","author":"Kim","year":"1998","journal-title":"J Immunol"},{"key":"2020071612145003100_R161","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0003-4975(98)00525-6","article-title":"Nitric oxide downregulates lung macrophage inflammatory cytokine production.","volume":"66","author":"Meldrum","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"2020071612145003100_R162","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.ATV.18.9.1456","article-title":"Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels.","volume":"18","author":"Tomita","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071612145003100_R163","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0024-3205(99)00431-2","article-title":"Exogenous nitric oxide modulates cytokine production in human leukocytes.","volume":"65","author":"Kallmann","year":"1999","journal-title":"Life Sci"},{"key":"2020071612145003100_R164","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jlb.66.5.829","article-title":"Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide.","volume":"66","author":"Obermeier","year":"1999","journal-title":"J Leukoc Biol"},{"key":"2020071612145003100_R165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1165\/ajrcmb.21.3.3611","article-title":"Nitric oxide blocks nuclear factor \u03baB activation in alveolar macrophages.","volume":"21","author":"Raychaudhuri","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2020071612145003100_R166","doi-asserted-by":"crossref","first-page":"C523","DOI":"10.1152\/ajpcell.1999.277.3.C523","article-title":"Endotoxin-mediated nitric oxide synthesis inhibits IL-1 \u03b2 gene transcription in ANA-1 murine macrophages","volume":"277","author":"Schroeder","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071612145003100_R167","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1073\/pnas.130511497","article-title":"Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption.","volume":"97","author":"t Hof","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R168","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/8756-3282(96)00005-1","article-title":"Nitric oxide donor alleviates ovariectomy-induced bone loss.","volume":"18","author":"Wimalawansa","year":"1996","journal-title":"Bone"},{"key":"2020071612145003100_R169","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s002230050011","article-title":"Restoration of ovariectomy-induced osteopenia by nitroglycerin.","volume":"66","author":"Wimalawansa","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R170","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1359\/jbmr.2000.15.11.2240","article-title":"Nitroglycerein therapy is as efficacious as standard estrogen replacement therapy (Premarin) in prevention of oophorectomy-induced bone loss: a human pilot clinical study.","volume":"15","author":"Wimalawansa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R171","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3181\/00379727-217-44201","article-title":"Mechanisms of cardioprotection by estrogens.","volume":"217","author":"Subbiah","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071612145003100_R172","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1210\/endo.141.10.7693","article-title":"Antiinflammatory effects of estrogen on microglial activation.","volume":"141","author":"Bruce-Keller","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R173","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1043-2760(99)00231-3","article-title":"Sex is all in the brain: report of a Novartis Foundation Symposium on the neuronal and cognitive effects of oestrogens, London UK, 7\u20139 September 1999.","volume":"11","author":"Melton","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612145003100_R174","first-page":"38","article-title":"Changes in enzymatic antioxidant defense system in blood and endometrial tissues of women after menopause.","volume":"97","author":"Gurdol","year":"1997","journal-title":"Res Comm Mol Pathol Pharmacol"},{"key":"2020071612145003100_R175","first-page":"173","article-title":"Effects of estradiol and medroxyprogesterone acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoic women.","volume":"82","author":"Massafra","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R176","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1677\/joe.0.1670447","article-title":"Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle.","volume":"167","author":"Massafra","year":"2000","journal-title":"J Endocrinol"},{"key":"2020071612145003100_R177","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ Res"},{"key":"2020071612145003100_R178","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","article-title":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation: contribution to alterations of vasomotor tone.","volume":"97","author":"Rajagopalan","year":"1996","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R179","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.97.22.2197","article-title":"Estrogen modulates AT1 receptor gene expression in vitro and in vivo.","volume":"97","author":"Nickenig","year":"1998","journal-title":"Circulation"},{"key":"2020071612145003100_R180","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/01.CIR.95.6.1378","article-title":"Antioxidant protection of LDL by physiological concentrations of 17\u03b2-estradiol. Requirement for estradiol modification.","volume":"95","author":"Shwaery","year":"1997","journal-title":"Circulation"},{"key":"2020071612145003100_R181","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00042192-200101000-00010","article-title":"17\u03b2-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism.","volume":"8","author":"Yoon","year":"2001","journal-title":"Menopause"},{"key":"2020071612145003100_R182","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1043-2760(01)00377-0","article-title":"Rapid actions of plasma membrane estrogen receptors.","volume":"12","author":"Kelly","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612145003100_R183","doi-asserted-by":"crossref","first-page":"38540","DOI":"10.1074\/jbc.M007555200","article-title":"Estrogen signals to the preservation of endothelial cell form and function.","volume":"275","author":"Razandi","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R184","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1210\/endo.142.6.8071","article-title":"Estrogen receptor (ER)\u03b1 and ER\u03b2 exhibit unique pharmacological properties when coupled to activation of the mitogen-activated protein kinase pathway.","volume":"142","author":"Wade","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612145003100_R185","doi-asserted-by":"crossref","first-page":"27873","DOI":"10.1074\/jbc.M010984200","article-title":"Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1\/2 pathway and serum response elements.","volume":"276","author":"De Jager","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R186","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.4049\/jimmunol.141.9.3101","article-title":"Differential inhibition of IL-1 and TNF-\u03b1 mRNA expression by agents which block second messenger pathways in murine macrophages.","volume":"141","author":"Kovacs","year":"1988","journal-title":"J Immunol"},{"key":"2020071612145003100_R187","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/intimm\/2.11.1047","article-title":"Regulation of interleukin 6 production in T helper cells.","volume":"2","author":"Zubiaga","year":"1990","journal-title":"Int Immunol"},{"key":"2020071612145003100_R188","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.4049\/jimmunol.149.12.3894","article-title":"Role of protein kinase C activity in tumor necrosis factor-\u03b1 gene expression. Involvement at the transcriptional level.","volume":"149","author":"Chung","year":"1992","journal-title":"J Immunol"},{"key":"2020071612145003100_R189","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.153.4.1818","article-title":"Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-\u03b1 and IL-1 \u03b2 production by human monocytes.","volume":"153","author":"Shapira","year":"1994","journal-title":"J Immunol"},{"key":"2020071612145003100_R190","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1165\/ajrcmb.20.4.3420","article-title":"Both Erk and p38 kinases are necessary for cytokine gene transcription.","volume":"20","author":"Carter","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2020071612145003100_R191","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.162.9.5367","article-title":"The role of p38 mitogen-activated protein kinase in IL-1 \u03b2 transcription.","volume":"162","author":"Baldassare","year":"1999","journal-title":"J Immunol"},{"key":"2020071612145003100_R192","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1523-1755.1999.00664.x","article-title":"Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.","volume":"56","author":"Leonard","year":"1999","journal-title":"Kidney Int"},{"key":"2020071612145003100_R193","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1074\/jbc.M005486200","article-title":"Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-\u03b1 (TNF-\u03b1) mRNA induction. Evidence for selective destabilization of TNF-\u03b1 transcripts.","volume":"276","author":"Rutault","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R194","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.4049\/jimmunol.165.12.7180","article-title":"Vitamin C inhibits NF-\u03baB activation by TNF via the activation of p38 mitogen-activated protein kinase.","volume":"165","author":"Bowie","year":"2000","journal-title":"J Immunol"},{"key":"2020071612145003100_R195","first-page":"369","article-title":"Gonadal steroids and immunity.","volume":"17","author":"Olsen","year":"1996","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002239900570","article-title":"Bone and cytokines: beyond IL-1, IL-6 and TNF-\u03b1.","volume":"64","author":"Rifas","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R197","first-page":"375","article-title":"T lymphocyte subsets in osteoporosis. Effect of 1-\u03b1 hydroxyvitamin D3.","volume":"10","author":"Fujita","year":"1984","journal-title":"Miner Electrolyte Metab"},{"key":"2020071612145003100_R198","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jbmr.5650050413","article-title":"Quantitative bone histomorphometry and circulating T lymphocyte subsets in postmenopausal osteoporosis.","volume":"5","author":"Imai","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R199","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-\u03b1.","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R200","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.167.1.542","article-title":"Estrogen treatment down-regulates TNF-\u03b1 production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice.","volume":"167","author":"Ito","year":"2001","journal-title":"J Immunol"},{"key":"2020071612145003100_R201","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI117424","article-title":"Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.","volume":"94","author":"Masuzawa","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R202","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/endo.141.11.7765","article-title":"Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice.","volume":"141","author":"Danilovich","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1359\/jbmr.2000.15.3.541","article-title":"Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.","volume":"15","author":"Onoe","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R204","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0167-5699(94)90211-9","article-title":"Pregnancy: a clue to normal regulation of B lymphopoiesis.","volume":"15","author":"Kincade","year":"1994","journal-title":"Immunol Today"},{"key":"2020071612145003100_R205","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood.V97.9.2708","article-title":"Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators.","volume":"97","author":"Kouro","year":"2001","journal-title":"Blood"},{"key":"2020071612145003100_R206","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.167.4.1886","article-title":"Cutting edge: expansion and activation of a population of autoreactive marginal zone b cells in a model of estrogen-induced lupus.","volume":"167","author":"Grimaldi","year":"2001","journal-title":"J Immunol"},{"key":"2020071612145003100_R207","first-page":"S159","article-title":"Immature B-lymphopoiesis accumulating in estrogen deficiency stimulate IL-6 production by mouse bone marrow stromal cells","volume":"10","author":"Seo","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R208","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.4049\/jimmunol.155.5.2359","article-title":"Stimulation of human bone marrow stromal cell tyrosine kinases and IL-6 production by contact with B lymphocytes.","volume":"155","author":"Zarvis","year":"1995","journal-title":"J Immunol"},{"key":"2020071612145003100_R209","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0167-5699(00)01718-7","article-title":"Osteoprotegerin ligand: a regulator of immune responses and bone physiology.","volume":"21","author":"Kong","year":"2000","journal-title":"Immunol Today"},{"key":"2020071612145003100_R210","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1359\/jbmr.2000.15.7.1321","article-title":"Prostaglandin E2 induces expression of receptor activator of nuclear factor-\u03ba B ligand\/osteoprotegerin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.","volume":"15","author":"Kanematsu","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R211","first-page":"500","article-title":"Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6.","volume":"23","author":"Jilka","year":"1995","journal-title":"Exp Hematol"},{"key":"2020071612145003100_R212","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","article-title":"Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.","volume":"107","author":"Denhardt","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R213","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI10420","article-title":"Bromocriptine restores tolerance in estrogen-treated mice.","volume":"106","author":"Peeva","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R214","first-page":"40","author":"Grossman","year":"1991"},{"key":"2020071612145003100_R215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","article-title":"Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications.","volume":"129","author":"Chrousos","year":"1998","journal-title":"Ann Intern Med"},{"key":"2020071612145003100_R216","first-page":"374","article-title":"Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.","volume":"108","author":"Elenkov","year":"1996","journal-title":"Proc Assoc Am Physicians"},{"key":"2020071612145003100_R217","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-123-9-199511010-00005","article-title":"Changes in energy balance and body composition at menopause: a controlled longitudinal study.","volume":"123","author":"Poehlman","year":"1995","journal-title":"Ann Intern Med"},{"key":"2020071612145003100_R218","doi-asserted-by":"crossref","first-page":"12735","DOI":"10.1073\/pnas.97.23.12735","article-title":"Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity.","volume":"97","author":"Jones","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R219","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1073\/pnas.97.23.12729","article-title":"Increased adipose tissue in male and female estrogen receptor-\u03b1 knockout mice.","volume":"97","author":"Heine","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R220","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0026-0495(91)90037-W","article-title":"Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause.","volume":"40","author":"Haarbo","year":"1991","journal-title":"Metabolism"},{"key":"2020071612145003100_R221","first-page":"3338","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.","volume":"85","author":"Bastard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R222","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ.","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612145003100_R223","first-page":"847","article-title":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.","volume":"83","author":"Fried","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R224","doi-asserted-by":"crossref","first-page":"16449","DOI":"10.1074\/jbc.270.27.16449","article-title":"Aromatase P450 gene expression in human adipose tissue. Role of a Jak\/STAT pathway in the regulation of the adipose-specific promoter.","volume":"270","author":"Zhao","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/bbrc.1999.0252","article-title":"A new member of tumor necrosis factor ligand familiy, ODF\/OPGL\/TRANCE\/RANKL, regulates osteoclast differentiation and function.","volume":"256","author":"Takahashi","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R226","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R227","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"2020071612145003100_R228","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development.","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"2020071612145003100_R229","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an \u03b1 v\u03b2 3-induced NF-\u03baB-dependent survival factor for endothelial cells.","volume":"275","author":"Malyankar","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R230","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"2020071612145003100_R231","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis.","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"2020071612145003100_R232","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R233","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/endo.142.6.8220","article-title":"17\u03b2-Estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-\u03b1.","volume":"142","author":"Saika","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612145003100_R234","first-page":"2355","article-title":"Clinical review 114: hot topic. The role of receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.","volume":"85","author":"Hofbauer","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R235","first-page":"631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women.","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R236","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-\u03baB ligand: modulation of the expression by osteotropic factors and cytokines.","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R237","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.1998.9394","article-title":"Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.","volume":"250","author":"Hofbauer","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R238","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.","volume":"25","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"key":"2020071612145003100_R239","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1006\/bbrc.1998.9035","article-title":"Osteoprotegerin mRNA is increased by interleukin-1 \u03b1 in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.","volume":"248","author":"Vidal","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R240","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.4223","article-title":"Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells.","volume":"280","author":"Brandstrom","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R241","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-\u03baB ligand (RANKL)-induced JNK activation.","volume":"276","author":"Srivastava","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R242","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/clin.1997.4409","article-title":"TGF-\u03b2: a critical modulator of immune cell function.","volume":"84","author":"Letterio","year":"1997","journal-title":"Clin Immunol Immunpathol"},{"key":"2020071612145003100_R243","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3181\/00379727-214-44066","article-title":"Role of transforming growth factor-\u03b2 in tissue injury and repair.","volume":"214","author":"Grande","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071612145003100_R244","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor \u03b2 in human disease.","volume":"342","author":"Blobe","year":"2000","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R245","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/endo.137.2.8593810","article-title":"Osteoclasts and transforming growth factor-\u03b2: estrogen-mediated isoform-specific regulation of production.","volume":"137","author":"Robinson","year":"1996","journal-title":"Endocrinology"},{"key":"2020071612145003100_R246","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-\u03b2.","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat Med"},{"key":"2020071612145003100_R247","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/endo-129-6-3313","article-title":"Modulation of transforming growth factor-\u03b2 production in normal human osteoblast-like cells by 17 \u03b2-estradiol and parathyroid hormone.","volume":"129","author":"Oursler","year":"1991","journal-title":"Endocrinology"},{"key":"2020071612145003100_R248","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1210\/endo.137.5.8612550","article-title":"Estrogen and raloxifene stimulate transforming growth factor-\u03b2 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.","volume":"137","author":"Yang","year":"1996","journal-title":"Endocrinology"},{"key":"2020071612145003100_R249","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/jsre.1998.5487","article-title":"Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor \u03b2 1.","volume":"80","author":"Selzman","year":"1998","journal-title":"J Surg Res"},{"key":"2020071612145003100_R250","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm1197-1209","article-title":"Estrogen accelerates cutaneous wound healing associated with an increase in TGF-\u03b21 levels.","volume":"3","author":"Ashcroft","year":"1997","journal-title":"Nat Med"},{"key":"2020071612145003100_R251","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2796.2000.00648.x","article-title":"Increased plasma concentrations of TGF-\u03b21 after hormone replacement therapy.","volume":"247","author":"Djurovic","year":"2000","journal-title":"J Intern Med"},{"key":"2020071612145003100_R252","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/bbrc.1994.1446","article-title":"The effect of long-term ovarian hormone deficiency on transforming growth factor-\u03b2 and bone matrix protein mRNA expression in rat femora.","volume":"200","author":"Westerlind","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R253","doi-asserted-by":"crossref","first-page":"12190","DOI":"10.1073\/pnas.89.24.12190","article-title":"Ovariectomy selectively reduces the concentration of transforming growth factor \u03b2 in rat bone: implications for estrogen deficiency-associated bone loss.","volume":"89","author":"Finkelman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R254","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/bbrc.1993.1954","article-title":"Ovariectomy decreases the mRNA levels of transforming growth factor-\u03b21 and increases the mRNA levels of osteocalcin in rat bone in vivo.","volume":"194","author":"Ikeda","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R255","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.273.5279.1222","article-title":"Identification of an estrogen response element activated by metabolites of 17\u03b2-estradiol and raloxifene.","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"2020071612145003100_R256","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.1998.13.4.716","article-title":"Concentration of transforming growth factor \u03b2 in human bone tissue: relationship to age, menopause, bone turnover, and bone volume.","volume":"13","author":"Pfeilschifter","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R257","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm1095-1067","article-title":"Tamoxifen elevates transforming growth factor-\u03b2 and suppresses diet-induced formation of lipid lesions in mouse aorta.","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat Med"},{"key":"2020071612145003100_R258","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0002-9343(99)00115-1","article-title":"Role and regulation of cyclooxygenase-2 during inflammation.","volume":"106","author":"Simon","year":"1999","journal-title":"Am J Med"},{"key":"2020071612145003100_R259","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI118066","article-title":"Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.","volume":"96","author":"Kawaguchi","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R260","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/endo-121-2-819","article-title":"Prostaglandin production by calvariae from sham operated and oophorectomized rats: effect of 17 \u03b2-estradiol in vivo.","volume":"121","author":"Feyen","year":"1987","journal-title":"Endocrinology"},{"key":"2020071612145003100_R261","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5122(98)00046-2","article-title":"Hormone replacement therapy and urinary prostaglandins in postmenopausal women.","volume":"30","author":"Akgul","year":"1998","journal-title":"Maturitas"},{"key":"2020071612145003100_R262","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0006-291X(89)91122-4","article-title":"Inhibition by 17 \u03b2-estradiol of PTH stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae.","volume":"163","author":"Pilbeam","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R263","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1902\/jop.1993.64.11.1075","article-title":"Effects of sex hormones on production of prostaglandin E2 by human peripheral monocytes.","volume":"64","author":"Miyagi","year":"1993","journal-title":"J Periodontol"},{"key":"2020071612145003100_R264","doi-asserted-by":"crossref","first-page":"PL167","DOI":"10.1016\/S0024-3205(99)00383-5","article-title":"Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures","volume":"65","author":"Seeger","year":"1999","journal-title":"Life Sci"},{"key":"2020071612145003100_R265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s000110050617","article-title":"The induction of cyclooxygenase-2 by 17\u03b2-estradiol in endothelial cells is mediated through protein kinase C.","volume":"49","author":"Akarasereenont","year":"2000","journal-title":"Inflamm Res"},{"key":"2020071612145003100_R266","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0015-0282(99)00482-3","article-title":"Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells.","volume":"73","author":"Mikkola","year":"2000","journal-title":"Fertil Steril"},{"key":"2020071612145003100_R267","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0012-1606(92)90175-G","article-title":"The biology of granulocyte-macrophage colony-stimulating factor: effects on hematopoietic and nonhemoatopoietic cells.","volume":"151","author":"Baldwin","year":"1992","journal-title":"Dev Biol"},{"key":"2020071612145003100_R268","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1097-4652(199804)175:1<99::AID-JCP11>3.0.CO;2-J","article-title":"Inhibition of bone resorption by 17\u03b2-estradiol in human bone marrow cultures.","volume":"175","author":"Sarma","year":"1998","journal-title":"J Cell Physiol"},{"key":"2020071612145003100_R269","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endo.140.1.6451","article-title":"Macrophage colony stimulating factor transcripts are differentially regulated in rat bone-marrow by gender hormones.","volume":"140","author":"Lea","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R270","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1172\/JCI4561","article-title":"Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.","volume":"102","author":"Srivastava","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R271","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R272","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.3388021","article-title":"Evidence of estrogen receptors in normal human osteoblast-like cells.","volume":"241","author":"Eriksen","year":"1988","journal-title":"Science"},{"key":"2020071612145003100_R273","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.3164526","article-title":"Estrogen binding, receptor mRNA, and biological response in osteoblast-like osteosarcoma cells.","volume":"241","author":"Komm","year":"1988","journal-title":"Science"},{"key":"2020071612145003100_R274","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1073\/pnas.88.15.6613","article-title":"Avian osteoclasts as estrogen target cells.","volume":"88","author":"Oursler","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R275","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0039-128X(95)00056-V","article-title":"Estrogen receptor mRNA is expressed in vivo in rat calvarial periosteum.","volume":"60","author":"Westerlind","year":"1995","journal-title":"Steroids"},{"key":"2020071612145003100_R276","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(96)00346-8","article-title":"Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction.","volume":"20","author":"Hoyland","year":"1997","journal-title":"Bone"},{"key":"2020071612145003100_R277","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1210\/endo.138.10.5575","article-title":"Expression of estrogen receptor \u03b2 in rat bone.","volume":"138","author":"Onoe","year":"1997","journal-title":"Endocrinology"},{"key":"2020071612145003100_R278","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/endo.133.2.8393768","article-title":"Demonstration of estrogen and vitamin D receptors in bone marrow-dervied stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3.","volume":"133","author":"Bellido","year":"1993","journal-title":"Endocrinology"},{"key":"2020071612145003100_R279","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.8480174","article-title":"Cytokines and estrogen in bone: antiosteoporotic effects.","volume":"260","author":"Horowitz","year":"1993","journal-title":"Science"},{"key":"2020071612145003100_R280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4049\/jimmunol.162.1.35","article-title":"Androgens alter the cytokine profile and produce encephathogenicity of myelin-reactive T cells.","volume":"162","author":"Bebo Jr","year":"1999","journal-title":"J Immunol"},{"key":"2020071612145003100_R281","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(98)00039-8","article-title":"Estradiol binding to cell surface raises cytosolic free calcium in T cells.","volume":"422","author":"Benten","year":"1998","journal-title":"FEBS Lett"},{"key":"2020071612145003100_R282","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4049\/jimmunol.158.1.446","article-title":"Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects.","volume":"158","author":"Gilmore","year":"1997","journal-title":"J Immunol"},{"key":"2020071612145003100_R283","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI8672","article-title":"M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.","volume":"105","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R284","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.","volume":"332","author":"Manolagas","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2020071612145003100_R285","doi-asserted-by":"crossref","first-page":"S505","DOI":"10.1002\/jbmr.5650081315","article-title":"Cytokines and growth factors in the regulation of bone remodeling","volume":"8","author":"Mundy","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R286","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0169-6009(08)80149-3","article-title":"Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development.","volume":"24","author":"Passeri","year":"1994","journal-title":"Bone Miner"},{"key":"2020071612145003100_R287","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1359\/jbmr.1997.12.6.869","article-title":"Regulation of osteoclast function.","volume":"12","author":"Suda","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R288","first-page":"E868","article-title":"Role of interleukin-6 and prostaglandins in the effect of monocyte-conditioned medium on osteoclast formation","volume":"267","author":"Kanatani","year":"1994","journal-title":"Am J Physiol"},{"key":"2020071612145003100_R289","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.144.11.4226","article-title":"IL-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release.","volume":"144","author":"Kurihara","year":"1990","journal-title":"J Immunol"},{"key":"2020071612145003100_R290","first-page":"457","article-title":"Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.","volume":"76","author":"O\u2019Keefe","year":"1997","journal-title":"Lab Invest"},{"issue":"Suppl 1","key":"2020071612145003100_R291","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1007\/BF03354648","article-title":"Cytokines and osteoclast activity","volume":"56","author":"Pacifici","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R292","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbmr.5650040116","article-title":"Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro.","volume":"4","author":"Pfeilschifter","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R293","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/8756-3282(95)00185-G","article-title":"Modulation of osteoclast differentiation by local factors.","volume":"17","author":"Suda","year":"1995","journal-title":"Bone"},{"key":"2020071612145003100_R294","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/306378a0","article-title":"An interleukin-1-like factor stimulates bone resorption in vitro.","volume":"306","author":"Gowen","year":"1983","journal-title":"Nature"},{"key":"2020071612145003100_R295","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1073\/pnas.85.14.5235","article-title":"Infusions of recombinant human interleukins 1 \u03b1 and 1 \u03b2 cause hypercalcemia in normal mice.","volume":"85","author":"Sabatini","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R296","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/endo-125-3-1142","article-title":"Effects of interleukin-1 on bone turnover in normal mice.","volume":"125","author":"Boyce","year":"1989","journal-title":"Endocrinology"},{"key":"2020071612145003100_R297","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.136.7.2478","article-title":"Actions of interleukin-1, interleukin-2, and interferon \u03b3 on bone resorption in vitro.","volume":"136","author":"Gowen","year":"1986","journal-title":"J Immunol"},{"key":"2020071612145003100_R298","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1172\/JCI113042","article-title":"Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro.","volume":"80","author":"Lorenzo","year":"1987","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R299","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"key":"2020071612145003100_R300","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/endo-124-3-1424","article-title":"Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resoprtion in nude mice.","volume":"124","author":"Johnson","year":"1989","journal-title":"Endocrinology"},{"key":"2020071612145003100_R301","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jbmr.5650070502","article-title":"Interleukin-6: an osteotropic factor?","volume":"7","author":"Roodman","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R302","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","article-title":"Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.","volume":"91","author":"Tanaka","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R303","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S8756-3282(98)00077-5","article-title":"Cytokines, bone remodeling, and estrogen deficiency: a 1998 update.","volume":"23","author":"Jilka","year":"1998","journal-title":"Bone"},{"key":"2020071612145003100_R304","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbmr.5650060307","article-title":"Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype.","volume":"6","author":"Kurihara","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R305","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0006-291X(89)90851-6","article-title":"Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis.","volume":"162","author":"Lowik","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R306","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption.","volume":"145","author":"Ishimi","year":"1990","journal-title":"J Immunol"},{"key":"2020071612145003100_R307","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s002239900710","article-title":"Aging and cytokine production.","volume":"65","author":"Pacifici","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R308","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcp.1040910303","article-title":"Conditions controlling the proliferation of hematopoietic cells in vitro.","volume":"91","author":"Dexter","year":"1977","journal-title":"J Cell Physiol"},{"key":"2020071612145003100_R309","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1097-4652(199607)168:1<199::AID-JCP24>3.0.CO;2-1","article-title":"Tumor necrosis factor-\u03b1 induces transcription of the colony-stimulating factor-1 gene in murine osteoblasts.","volume":"168","author":"Kaplan","year":"1996","journal-title":"J Cell Physiol"},{"key":"2020071612145003100_R310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF02556317","article-title":"Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by osteoblastic cell MC3T3-E1.","volume":"44","author":"Felix","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R311","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1172\/JCI114457","article-title":"Transcriptional and posttranscriptional regulation of macrophage-specific colony stimulating factor gene expression by tumor necrosis factor. Involvement of arachidonic acid metabolites.","volume":"85","author":"Sherman","year":"1990","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R312","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/endo-129-3-1513","article-title":"The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro.","volume":"129","author":"Littlewood","year":"1991","journal-title":"Endocrinology"},{"key":"2020071612145003100_R313","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.145.1.161","article-title":"IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA.","volume":"145","author":"Elias","year":"1990","journal-title":"J Immunol"},{"key":"2020071612145003100_R314","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/jbmr.5650061204","article-title":"Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1.","volume":"6","author":"Linkhart","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R315","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s001980070028","article-title":"Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.","volume":"11","author":"Aubin","year":"2000","journal-title":"Osteoporosis Int"},{"key":"2020071612145003100_R316","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R317","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"2020071612145003100_R318","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R319","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1359\/jbmr.1998.13.5.846","article-title":"Colony-stimulating factor-1 stimulates the fusion process in osteoclasts.","volume":"13","author":"Amano","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R320","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/bbrc.1998.8783","article-title":"Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells.","volume":"247","author":"Brandstrom","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R321","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis inhibitory factor and is identical to TRANCE\/RANKL.","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R322","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.1998.8610","article-title":"Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1\u03b1,25-dihydroxyvitamin D3, prostaglandin E2 or parathyroid hormone in the microenvironment of bone.","volume":"246","author":"Tsukii","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R323","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/endo.139.7.6085","article-title":"Prostaglandin E2, interleukin 1\u03b1, and tumor necrosis factor-\u03b1 increase human osteoclast formation and bone resorption in vitro.","volume":"139","author":"Lader","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612145003100_R324","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jbmr.5650060212","article-title":"Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro.","volume":"6","author":"Akatsu","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R325","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/art.1780311206","article-title":"Actions of recombinant human \u03b3-interferon and tumor necrosis factor \u03b1 on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro.","volume":"31","author":"Gowen","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2020071612145003100_R326","doi-asserted-by":"crossref","first-page":"27091","DOI":"10.1074\/jbc.273.42.27091","article-title":"Transforming growth factor-\u03b2 stimulates the production of osteoprotegerin\/osteoclastogenesis inhibitory factor by bone marrow stromal cells.","volume":"273","author":"Takai","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R327","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/bbrc.1998.8993","article-title":"Tumor necrosis factor-\u03b1 and -\u03b2 upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells.","volume":"248","author":"Brandstrom","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R328","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","article-title":"STAT3 activation in stromal\/osteoblastic cells is required for induction of the receptor activator of NF-\u03baB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone.","volume":"274","author":"O\u2019Brien","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R329","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor \u03b1 stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction.","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J Exp Med"},{"key":"2020071612145003100_R330","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","article-title":"Tumor necrosis factor-\u03b1 induces differentiation of and bone resorption by osteoclasts.","volume":"275","author":"Azuma","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R331","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/endo.140.4.6647","article-title":"Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion.","volume":"140","author":"Wani","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R332","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R333","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI113647","article-title":"Transforming growth factor \u03b2 inhibits bone resorption in fetal rat long bone cultures.","volume":"82","author":"Pfeilschifter","year":"1988","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R334","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1073\/pnas.85.15.5683","article-title":"Transforming growth factor \u03b2 inhibits formation of osteoclast-like cells in long-term human marrow cultures.","volume":"85","author":"Chenu","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R335","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1006\/bbrc.1998.9723","article-title":"Transforming growth factor-\u03b21 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic\/stromal cells and inhibits the survival of murine osteoclast-like cells.","volume":"252","author":"Murakami","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R336","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.165.8.4254","article-title":"Endogenous production of TGF-\u03b2 is essential for osteoclastogenesis induced by a combination of receptor activator of NF-\u03baB ligand and macrophage-colony-stimulating factor.","volume":"165","author":"Kaneda","year":"2000","journal-title":"J Immunol"},{"key":"2020071612145003100_R337","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/bbrc.1999.1632","article-title":"TGF-\u03b2 enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.","volume":"265","author":"Sells Galvin","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R338","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro.","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R339","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S8756-3282(99)00275-6","article-title":"Transforming growth factor-\u03b2 increases interleukin-6 transcripts in osteoblasts.","volume":"26","author":"Franchimont","year":"2000","journal-title":"Bone"},{"key":"2020071612145003100_R340","first-page":"1055","article-title":"Regulation of interleukin 6 expression in murine bone marrow stromal cells.","volume":"19","author":"Gimble","year":"1991","journal-title":"Exp Hematol"},{"key":"2020071612145003100_R341","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4049\/jimmunol.146.8.2633","article-title":"Effects of transforming growth factor-\u03b2 and IL-1 \u03b1 on prostaglandin synthesis in serum-deprived osteoblastic cells.","volume":"146","author":"Marusic","year":"1991","journal-title":"J Immunol"},{"key":"2020071612145003100_R342","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1182\/blood.V76.7.1315.1315","article-title":"Selective regulation of the activity of different hematopoietic regulatory proteins by transforming growth factor \u03b2 1 in normal and leukemic myeloid cels.","volume":"76","author":"Lotem","year":"1990","journal-title":"Blood"},{"key":"2020071612145003100_R343","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.148.3.795","article-title":"IL-2 induces IL-6 production in human monocytes.","volume":"148","author":"Musso","year":"1992","journal-title":"J Immunol"},{"key":"2020071612145003100_R344","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.138.3.775","article-title":"Tumor necrosis factor \u03b1 and \u03b2 induce osteoblastic cells to stimulate osteoclastic bone resorption.","volume":"138","author":"Thomson","year":"1987","journal-title":"J Immunol"},{"key":"2020071612145003100_R345","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1084\/jem.164.1.104","article-title":"Osteoblasts mediated interleukin 1 stimulation of bone resorption by rat osteoclasts.","volume":"164","author":"Thomson","year":"1986","journal-title":"J Exp Med"},{"key":"2020071612145003100_R346","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/endo-120-5-2029","article-title":"Tumor necrosis factor-\u03b1 (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism.","volume":"120","author":"Tashjian Jr","year":"1987","journal-title":"Endocrinology"},{"key":"2020071612145003100_R347","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.","volume":"145","author":"Burgess","year":"1999","journal-title":"J Cell Biol"},{"key":"2020071612145003100_R348","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1210\/endo-129-3-1596","article-title":"Two distinct effects of recombinant human tumor necrosis factor-\u03b1 on osteoclast development and subsequent resorption of mineralized matrix.","volume":"129","author":"Van der Pluijm","year":"1991","journal-title":"Endocrinology"},{"key":"2020071612145003100_R349","doi-asserted-by":"crossref","first-page":"8799","DOI":"10.1074\/jbc.273.15.8799","article-title":"Activation of NF-\u03baB is involved in the survival of osteoclasts promoted by interleukin-1.","volume":"273","author":"Jimi","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R350","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1083\/jcb.142.5.1347","article-title":"Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption.","volume":"142","author":"Adebanjo","year":"1998","journal-title":"J Cell Biol"},{"key":"2020071612145003100_R351","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/endo.136.2.7835314","article-title":"Macrophage colony-stimulating factor and interleukin-1 \u03b1 maintain the survival of osteoclast-like cells.","volume":"136","author":"Jimi","year":"1995","journal-title":"Endocrinology"},{"key":"2020071612145003100_R352","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1074\/jbc.271.9.4605","article-title":"Interleukin-1 \u03b1 activates an NF-\u03baB-like factor in osteoclast-like cells.","volume":"271","author":"Jimi","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R353","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.178.5.1733","article-title":"Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts.","volume":"178","author":"Fuller","year":"1993","journal-title":"J Exp Med"},{"key":"2020071612145003100_R354","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.84.7.2024","article-title":"Modulation of type \u03b2 transforming growth factor activity in bone cultures by osteotropic hormones.","volume":"84","author":"Pfeilschifter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R355","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0304-4165(88)90127-4","article-title":"Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II.","volume":"966","author":"Mohan","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"2020071612145003100_R356","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/endo-123-3-1442","article-title":"Tumor necrosis factor-\u03b1 inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures.","volume":"123","author":"Centrella","year":"1988","journal-title":"Endocrinology"},{"key":"2020071612145003100_R357","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1210\/endo-120-6-2494","article-title":"Effects of interferon-\u03b3 and other cytokines on collagen synthesis in fetal rat bone cultures.","volume":"120","author":"Smith","year":"1987","journal-title":"Endocrinology"},{"key":"2020071612145003100_R358","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1210\/mend-4-2-184","article-title":"Interleukin-1 \u03b1 and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism.","volume":"4","author":"Harrison","year":"1990","journal-title":"Mol Endocrinol"},{"key":"2020071612145003100_R359","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jbmr.5650020612","article-title":"Interleukin-1 \u03b2 is a potent inhibitor of bone formation in vitro.","volume":"2","author":"Stashenko","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R360","first-page":"15","article-title":"Interleukin-1 \u03b2 stimulates bone resorption and inhibits bone formation in vivo.","volume":"10","author":"Nguyen","year":"1991","journal-title":"Lymphokine Cytokine Res"},{"key":"2020071612145003100_R361","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/endo.141.11.7739","article-title":"Inhibition of osteoblast differentiation by tumor necrosis factor-\u03b1.","volume":"141","author":"Gilbert","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R362","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI111819","article-title":"Stimulation of the proliferation of human bone cells in vitro by human monocyte products with interleukin-1 activity.","volume":"75","author":"Gowen","year":"1985","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R363","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/endo-118-1-74","article-title":"Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae.","volume":"118","author":"Canalis","year":"1986","journal-title":"Endocrinology"},{"key":"2020071612145003100_R364","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/cyto.1995.0085","article-title":"Involvement of interleukin 1 and tumour necrosis factor \u03b1 as endogenous growth factors in human osteoblastic cells.","volume":"7","author":"Modrowski","year":"1995","journal-title":"Cytokine"},{"key":"2020071612145003100_R365","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-5793(86)80758-X","article-title":"Human purified interleukin-1 inhibits DNA synthesis and cell growth of osteoblastic cell line (MC3T3-E1), but enhances alkaline phosphatase activity in the cells.","volume":"203","author":"Hanazawa","year":"1986","journal-title":"FEBS Lett"},{"key":"2020071612145003100_R366","first-page":"27","article-title":"Transforming growth factor-\u03b2 gene family members and bone.","volume":"15","author":"Centrella","year":"1994","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R367","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9343(00)00684-7","article-title":"Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease.","volume":"110","author":"Raisz","year":"2001","journal-title":"Am J Med"},{"key":"2020071612145003100_R368","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1210\/endo.139.6.6128","article-title":"Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy.","volume":"139","author":"Lorenzo","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612145003100_R369","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice.","volume":"12","author":"Kimble","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R370","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI119333","article-title":"Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.","volume":"99","author":"Ammann","year":"1997","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"2020071612145003100_R371","first-page":"123","article-title":"An orally active inhibitor of cytokine synthesis prevents bone loss in the ovariectomized rat","volume":"11","author":"Bradbeer","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R372","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.5650101013","article-title":"In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.","volume":"10","author":"Most","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R373","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/j.1460-2075.1994.tb06368.x","article-title":"Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.","volume":"13","author":"Poli","year":"1994","journal-title":"EMBO J"},{"key":"2020071612145003100_R374","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jbmr.5650051006","article-title":"Effect of naproxen on cancellous bone in ovariectomized rats.","volume":"5","author":"Lane","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R375","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/blood.V87.6.2095.bloodjournal8762095","article-title":"Biological basis for interleukin-1 in disease.","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"2020071612145003100_R376","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/endo.136.7.7789332","article-title":"Simultaneous block of interleukin 1 and tumor necrosis factor is required to completely prevent bone loss in the early post-ovariectomy period.","volume":"136","author":"Kimble","year":"1995","journal-title":"Endocrinology"},{"key":"2020071612145003100_R377","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI11468","article-title":"The mechanisms of estrogen regulation of bone resorption.","volume":"106","author":"Riggs","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R378","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI12724","article-title":"Severe inflammatory arthritis and lympadenopathy in the absence of TNF.","volume":"107","author":"Campbell","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R379","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jbmr.5650100914","article-title":"Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6.","volume":"10","author":"Miyaura","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R380","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1359\/jbmr.2001.16.12.2215","article-title":"Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency.","volume":"16","author":"Sato","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R381","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1210\/endo.132.3.8440193","article-title":"Estrogen modulation of avian osteoclast lysosomal gene expression.","volume":"132","author":"Oursler","year":"1993","journal-title":"Endocrinology"},{"key":"2020071612145003100_R382","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1084\/jem.186.4.489","article-title":"Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.","volume":"186","author":"Kameda","year":"1997","journal-title":"J Exp Med"},{"key":"2020071612145003100_R383","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/mend.13.6.0299","article-title":"The actions and interactions of sex steroids and growth factors\/cytokines on the skeleton.","volume":"13","author":"Spelsberg","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2020071612145003100_R384","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI11653","article-title":"Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 \u03b2-estradiol.","volume":"107","author":"Di Gregorio","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R385","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3181\/00379727-206-43726","article-title":"Insulin-like growth factors and bone: the osteoporosis connection.","volume":"206","author":"Rosen","year":"1994","journal-title":"Proc Soc Exp Biol Med"},{"key":"2020071612145003100_R386","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/endo-125-2-825","article-title":"Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvaria and long bones.","volume":"125","author":"Ernst","year":"1989","journal-title":"Endocrinology"},{"key":"2020071612145003100_R387","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0169-6009(89)90023-8","article-title":"Biochemical effects of 17\u03b2-estradiol on UMR106 cells.","volume":"6","author":"Bankson","year":"1989","journal-title":"Bone Miner"},{"key":"2020071612145003100_R388","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0006-291X(89)92502-3","article-title":"Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone.","volume":"160","author":"Schmid","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R389","first-page":"E990","article-title":"Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 \u03b2 estradiol","volume":"267","author":"Slater","year":"1994","journal-title":"Am J Physiol"},{"key":"2020071612145003100_R390","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-291X(89)80062-2","article-title":"Estradiol stimulates in vitro the secretion of insulin-like groth factors by the clonal osteoblastic cell line, UMR106.","volume":"158","author":"Gray","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612145003100_R391","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s002239900395","article-title":"Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor.","volume":"62","author":"Kassem","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R392","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S8756-3282(98)00043-X","article-title":"Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix.","volume":"22","author":"Erdmann","year":"1998","journal-title":"Bone"},{"key":"2020071612145003100_R393","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01320913","article-title":"Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.","volume":"53","author":"Aerssens","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R394","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"2020071612145003100_R395","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women.","volume":"16","author":"Bekker","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R396","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"2020071612145003100_R397","first-page":"1648","article-title":"Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines.","volume":"77","author":"Cohen-Solal","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R398","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.","volume":"14","author":"Yano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R399","first-page":"2032","article-title":"Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.","volume":"86","author":"Scheidt-Nave","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R400","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses\u2019 health study.","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R401","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM197608192950805","article-title":"The pathogenesis of atherosclerosis (second of two parts).","volume":"295","author":"Ross","year":"1976","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R402","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disorder.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R403","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/107999099314234","article-title":"Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease.","volume":"19","author":"Krishnaswamy","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"2020071612145003100_R404","doi-asserted-by":"crossref","first-page":"12752","DOI":"10.1073\/pnas.220427097","article-title":"Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.","volume":"97","author":"Ludewig","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R405","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1515\/CCLM.1999.080","article-title":"Inflammation, the acute phase response and atherosclerosis.","volume":"37","author":"Whicher","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"2020071612145003100_R406","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med"},{"key":"2020071612145003100_R407","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R408","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R409","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","article-title":"High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"2020071612145003100_R410","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.142.2.549","article-title":"IL-1 stimulates IL-6 production in endothelial cells.","volume":"142","author":"Sironi","year":"1989","journal-title":"J Immunol"},{"key":"2020071612145003100_R411","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(92)90280-T","article-title":"Interleukin 6 transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits.","volume":"92","author":"Ikeda","year":"1992","journal-title":"Atherosclerosis"},{"key":"2020071612145003100_R412","first-page":"H2288","article-title":"Increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats","volume":"268","author":"Belmin","year":"1995","journal-title":"Am J Physiol"},{"key":"2020071612145003100_R413","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00042192-200107000-00013","article-title":"Estradiol regulates monocyte chemotactic protein-1 in human coronary artery smooth muscle cells: a mechanism for its antiatherogenic effect.","volume":"8","author":"Seli","year":"2001","journal-title":"Menopause"},{"key":"2020071612145003100_R414","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.2783498","article-title":"Interleukin-1 mitogenic activity for fibroblasts and smooth-muscle cells is due to PDGF-AA.","volume":"243","author":"Raines","year":"1989","journal-title":"Science"},{"key":"2020071612145003100_R415","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1043-4666(94)90013-2","article-title":"Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions.","volume":"6","author":"Seino","year":"1994","journal-title":"Cytokine"},{"key":"2020071612145003100_R416","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice.","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"key":"2020071612145003100_R417","first-page":"303","author":"Nicklin"},{"key":"2020071612145003100_R418","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/01.ATV.19.10.2364","article-title":"Interleukin-6 exacerbates early atherosclerosis in mice.","volume":"19","author":"Huber","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071612145003100_R419","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/jaut.1999.0339","article-title":"The inhibitory effects of transforming growth factor-\u03b2-1 (TGF-\u03b21) in autoimmune diseases.","volume":"14","author":"Prud\u2019homme","year":"2000","journal-title":"J Autoimmun"},{"key":"2020071612145003100_R420","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/370460a0","article-title":"Activation of transforming growth factor-\u03b2 is inhibited in transgenic apolipoprotein(a) mice.","volume":"362","author":"Grainger","year":"1994","journal-title":"Nature"},{"key":"2020071612145003100_R421","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm0195-74","article-title":"The serum concentration of active transforming growth factor-\u03b2 is severely depressed in advanced atherosclerosis.","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat Med"},{"key":"2020071612145003100_R422","first-page":"478","article-title":"Studies on TGF-\u03b2 1 gene expression in the intima of the human aorta in regions with high and low probability of developing atherosclerotic lesions.","volume":"8","author":"Borkowski","year":"1995","journal-title":"Mod Pathol"},{"key":"2020071612145003100_R423","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(00)00682-1","article-title":"Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17\u03b2-estradiol in apolipoprotein E-deficient mice.","volume":"156","author":"Elhage","year":"2001","journal-title":"Atherosclerosis"},{"key":"2020071612145003100_R424","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI200111380","article-title":"Lymphocytes are important in early atherosclerosis.","volume":"108","author":"Song","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R425","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1210\/endo.141.1.7377","article-title":"Loss of atheroprotective effect of estradiol in immunodeficient mice.","volume":"141","author":"Elhage","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R426","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S8756-3282(99)00243-4","article-title":"Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle.","volume":"26","author":"Chiu","year":"2000","journal-title":"Bone"},{"key":"2020071612145003100_R427","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03602539808996310","article-title":"Reactive oxygen-mediated protein oxidation in aging and disease.","volume":"30","author":"Stadtman","year":"1998","journal-title":"Drug Metab Rev"},{"key":"2020071612145003100_R428","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.84.5.489","article-title":"Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.","volume":"84","author":"Schmidt","year":"1999","journal-title":"Circulation"},{"key":"2020071612145003100_R429","doi-asserted-by":"crossref","first-page":"11463","DOI":"10.1074\/jbc.270.19.11463","article-title":"Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor IL-6.","volume":"270","author":"Yan","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/hrt.81.3.232","article-title":"Chlamydia pneumoniae and atherosclerosis.","volume":"81","author":"Wong","year":"1999","journal-title":"Heart"},{"key":"2020071612145003100_R431","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00003495-199957030-00002","article-title":"Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes.","volume":"75","author":"Schussheim","year":"1999","journal-title":"Drugs"},{"key":"2020071612145003100_R432","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1210\/endo.141.7.7537","article-title":"Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro.","volume":"141","author":"Masiukiewicz","year":"2000","journal-title":"Endocrinology"},{"key":"2020071612145003100_R433","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1359\/jbmr.2001.16.6.1045","article-title":"Mechanical strain and estrogen activate estrogen receptor \u03b1 in bone cells.","volume":"16","author":"Jessop","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R434","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s100380050132","article-title":"Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women.","volume":"44","author":"Tsukamoto","year":"1999","journal-title":"J Hum Genet"},{"key":"2020071612145003100_R435","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S8756-3282(98)00109-4","article-title":"Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine.","volume":"23","author":"Keen","year":"1998","journal-title":"Bone"},{"key":"2020071612145003100_R436","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/jbmr.2000.15.3.402","article-title":"Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1\u03b2 gene.","volume":"15","author":"Langdahl","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"2020071612145003100_R437","first-page":"S334","article-title":"An 86 basepair repeat in the interleukin 1 receptor antagonist gene is weakly associated with peak bone mass, but not with early postmenopausal bone loss or the response to HRT","volume":"14","author":"Langdahl","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R438","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5","article-title":"A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women.","volume":"44","author":"Ferrari","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2020071612145003100_R439","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1161\/01.CIR.103.18.2260","article-title":"Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms.","volume":"103","author":"Jones","year":"2001","journal-title":"Circulation"},{"key":"2020071612145003100_R440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S8756-3282(96)00363-8","article-title":"A sequence variation: 713\u20138delC in the transforming growth factor-\u03b21 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women.","volume":"20","author":"Langdahl","year":"1997","journal-title":"Bone"},{"key":"2020071612145003100_R441","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1359\/jbmr.2000.15.4.634","article-title":"Transforming growth factor-\u03b21 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women.","volume":"15","author":"Bertoldo","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R442","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1359\/jbmr.1998.13.10.1569","article-title":"Association of a polymorphism of the transforming growth factor \u03b2-1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women.","volume":"13","author":"Yamada","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R443","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1359\/jbmr.2000.15.3.415","article-title":"Association of transforming growth factor \u03b2-1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis.","volume":"15","author":"Yamada","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R444","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0002-9343(00)00468-X","article-title":"Association of a polymorphism of the transforming growth factor \u03b2-1 gene with prevalent vertebral fractures in Japanese women.","volume":"109","author":"Yamada","year":"2000","journal-title":"Am J Med"},{"key":"2020071612145003100_R445","author":"Hinke"},{"key":"2020071612145003100_R446","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.1990.tb30316.x","article-title":"Hot flashes: epidemiology and physiology. In: Flint M, Kronenberg F, Utian W, eds. Annals of the New York Academy of Sciences.","volume":"592","author":"Kronenberg","year":"1990","journal-title":"New York: The New York Academy of Sciences; vol"},{"key":"2020071612145003100_R447","first-page":"1135","article-title":"Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen\/progesterone therapy.","volume":"77","author":"Pacifici","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R448","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/eji.1830230950","article-title":"Increased cytokine production in mononuclear cells of healthy elderly people.","volume":"23","author":"Fagiolo","year":"1993","journal-title":"Eur J Immunol"},{"key":"2020071612145003100_R449","doi-asserted-by":"crossref","first-page":"M20","DOI":"10.1093\/gerona\/53A.1.M20","article-title":"Monocyte cytokine production in an elderly population: effect of age and inflammation","volume":"53A","author":"Roubenoff","year":"1998","journal-title":"J Gerontol"},{"key":"2020071612145003100_R450","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus.","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"key":"2020071612145003100_R451","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2249.1999.01045.x","article-title":"Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans.","volume":"118","author":"Bruunsgaard","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"2020071612145003100_R452","first-page":"1","article-title":"The influence of female sex steroids on glucose metabolism and insulin action.","volume":"738","author":"Godsland","year":"1996","journal-title":"J Intern Med Suppl"},{"key":"2020071612145003100_R453","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens.","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"key":"2020071612145003100_R454","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0024-3205(96)00122-1","article-title":"Sex steroid hormones and macrophage function.","volume":"59","author":"Miller","year":"1996","journal-title":"Life Sci"},{"key":"2020071612145003100_R455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/rep.0.1210003","article-title":"Cytokine control in human endometrium.","volume":"121","author":"Kelly","year":"2001","journal-title":"Reproduction"},{"key":"2020071612145003100_R456","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/edrv-11-2-386","article-title":"Progesterone as a bone-trophic hormone.","volume":"11","author":"Prior","year":"1990","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R457","first-page":"2832","article-title":"A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.","volume":"85","author":"Burger","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R458","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jcem.86.3.7369","article-title":"The role of androgens in women.","volume":"86","author":"Snyder","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R459","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/aje\/154.6.489","article-title":"Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation.","volume":"154","author":"Liu","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2020071612145003100_R460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2007-1016244","article-title":"Aromatase in aging women.","volume":"17","author":"Bulun","year":"1999","journal-title":"Semin Reprod Endocrinol"},{"key":"2020071612145003100_R461","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2007-1016242","article-title":"Changes in adrenocortical function with aging and therapeutic implications.","volume":"17","author":"Harper","year":"1999","journal-title":"Semin Reprod Endocrinol"},{"key":"2020071612145003100_R462","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5122(86)90025-3","article-title":"Steroid and gonadotropin levels in women during the peri-menopausal years.","volume":"8","author":"Longcope","year":"1986","journal-title":"Maturitas"},{"key":"2020071612145003100_R463","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s002239900421","article-title":"Orchidectomy increases bone marrow interleukin-6 levels in mice.","volume":"62","author":"Zhang","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2020071612145003100_R464","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/eje.0.1400271","article-title":"Androgen effects on bone metabolism: recent progress and controversies.","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071612145003100_R465","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1902\/jop.1999.70.6.604","article-title":"Androgens modulate interleukin-6 production by gingival fibroblasts in vitro.","volume":"70","author":"Gornstein","year":"1999","journal-title":"J Periodontol"},{"key":"2020071612145003100_R466","doi-asserted-by":"crossref","first-page":"26267","DOI":"10.1074\/jbc.271.42.26267","article-title":"Inhibition of NF\u03baB activity through maintenance of I\u03baB\u03b1 levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter.","volume":"271","author":"Keller","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612145003100_R467","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-2249.1996.d01-842.x","article-title":"Testosterone inhibits immunoglobulin production by human peripheal blood mononuclear cells.","volume":"106","author":"Kanda","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2020071612145003100_R468","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI117995","article-title":"Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens: the role of the androgen receptor.","volume":"95","author":"Bellido","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R469","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0047-6374(96)01807-6","article-title":"IL-6, DHEA and the ageing process.","volume":"93","author":"James","year":"1997","journal-title":"Mech Ageing Dev"},{"key":"2020071612145003100_R470","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/jcem.83.6.4876","article-title":"Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.","volume":"83","author":"Straub","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R471","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/0002-9378(93)90431-H","article-title":"Oral dehyroepiandrosterone in physiologic doses modulates immune function in postmenopausal women.","volume":"169","author":"Casson","year":"1993","journal-title":"Am J Obestet Gynecol"},{"key":"2020071612145003100_R472","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/08820139509066859","article-title":"Administration of dehydroepiandrosterone reverses the immune suppression induced by high dose antigen in mice.","volume":"24","author":"Kim","year":"1995","journal-title":"Immunol Invest"},{"key":"2020071612145003100_R473","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0736-5748(99)00067-2","article-title":"Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor \u03b1 and interleukin-6 in astrocytes.","volume":"17","author":"Kipper-Galperin","year":"1999","journal-title":"Int J Dev Neurosci"},{"key":"2020071612145003100_R474","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-5728(97)00244-0","article-title":"Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol.","volume":"84","author":"Padgett","year":"1998","journal-title":"J Neuroimmunol"},{"key":"2020071612145003100_R475","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1210\/endo.139.7.6118","article-title":"Dehydroepiandrosterone decreases serum tumor necrosis factor-\u03b1 and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats.","volume":"139","author":"Kimura","year":"1998","journal-title":"Endocrinology"},{"key":"2020071612145003100_R476","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.4049\/jimmunol.150.12.5219","article-title":"Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative.","volume":"150","author":"Daynes","year":"1993","journal-title":"J Immunol"},{"key":"2020071612145003100_R477","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.144.2.499","article-title":"IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro.","volume":"144","author":"Guerne","year":"1990","journal-title":"J Immunol"},{"key":"2020071612145003100_R478","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0303-7207(95)03549-M","article-title":"Sex hormones mediate interleukin-1 \u03b2 production by human osteoblastic HOBIT cells.","volume":"111","author":"Pivirotto","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612145003100_R479","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V85.6.1535.bloodjournal8561535","article-title":"Enhanced production of B lymphocytes after castration.","volume":"85","author":"Wilson","year":"1995","journal-title":"Blood"},{"key":"2020071612145003100_R480","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/jbmr.5650051114","article-title":"Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae.","volume":"5","author":"Pilbeam","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R481","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0960-0760(94)00165-I","article-title":"Regulation of c-fos expression and TGF-\u03b2 production by gonadal and adrenal androgens in normal human osteoblastic cells.","volume":"52","author":"Bodine","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071612145003100_R482","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1073\/pnas.96.2.505","article-title":"Androgens regulate bone resorption activity of isolated osteoclasts in vitro.","volume":"96","author":"Pederson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R483","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","article-title":"Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.","volume":"339","author":"Bilezikian","year":"1998","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R484","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contribution of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612145003100_R485","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1359\/jbmr.1999.14.8.1330","article-title":"The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.","volume":"14","author":"Hofbauer","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R486","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/art.1780360719","article-title":"Inflammation-induced cartilage degradation in female rodents. Protective role of sex hormones.","volume":"36","author":"da Silva","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2020071612145003100_R487","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/cyto.2001.0861","article-title":"Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis.","volume":"14","author":"Diodato","year":"2001","journal-title":"Cytokine"},{"key":"2020071612145003100_R488","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1073\/pnas.97.8.4279","article-title":"Dehydroepidandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue.","volume":"97","author":"Baulieu","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612145003100_R489","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R490","first-page":"2759","article-title":"Clinical review 82: androgens and the postmenopausal women.","volume":"81","author":"Davis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R491","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1210\/endo.140.6.6612","article-title":"Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.","volume":"140","author":"Bodine","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612145003100_R492","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(05)66951-6","article-title":"Statins and C-reactive protein.","volume":"353","author":"Kluft","year":"1999","journal-title":"Lancet"},{"key":"2020071612145003100_R493","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","article-title":"Long-term effects of pravastatin on plasma concentration of C-reactive protein.","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"2020071612145003100_R494","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease.","volume":"282","author":"LaRosa","year":"1999","journal-title":"JAMA"},{"key":"2020071612145003100_R495","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)39169-4","article-title":"Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis.","volume":"294","author":"Ando","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071612145003100_R496","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0021-9150(00)00725-5","article-title":"Reduced levels of TNF\u03b1lpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks.","volume":"157","author":"Solheim","year":"2001","journal-title":"Atherosclerosis"},{"key":"2020071612145003100_R497","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/endo.142.8.8340","article-title":"PPAR\u03b1 and GR differentially down-regulate the expression of nuclear factor-\u03baB-responsive genes in vascular endothelial cells.","volume":"142","author":"Xu","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612145003100_R498","first-page":"345","article-title":"Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.","volume":"36","author":"Madej","year":"1998","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2020071612145003100_R499","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199411033311803","article-title":"Improvement of glucose tolerance and insulin resistance in obese subjects treated with troglitazone.","volume":"331","author":"Nolan","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071612145003100_R500","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-\u03b3 agonists inhibit production of monocyte inflammatory cytokines.","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"2020071612145003100_R501","first-page":"1306","article-title":"Suppression of nuclear factor-\u03baB and stimulation of inhibitor \u03baB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.","volume":"86","author":"Ghanim","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R502","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism.","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"2020071612145003100_R503","first-page":"3250","article-title":"Nuclear factor-\u03baB suppressive and inhibitor-\u03baB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?","volume":"86","author":"Aljada","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612145003100_R504","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s001250051218","article-title":"Down-regulation of peroxisome proliferator-activated receptor\u03b3 expression by inflammatory cytokines and its reversal by thiazolidinediones.","volume":"42","author":"Tanaka","year":"1999","journal-title":"Diabetologia"},{"key":"2020071612145003100_R505","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1210\/endo.140.11.7116","article-title":"Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.","volume":"140","author":"Okazaki","year":"1999","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"2020071612145003100_R506","first-page":"S358","article-title":"Blockade of cytokine-mediated human osteoclastogenesis by activation of peroxisome proliferator-activated receptor-\u03b3 pathway","volume":"14","author":"Mbalaviele","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071612145003100_R507","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.","volume":"106","author":"Li","year":"2000","journal-title":"J Clin Invest"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/23\/1\/90\/8860656\/edrv0090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/23\/1\/90\/8860656\/edrv0090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:01:43Z","timestamp":1746100903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/23\/1\/90\/2424228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":507,"aliases":["10.1210\/er.23.1.90"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/edrv.23.1.0456","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,1]]}}}